Apart from its prominent effect on vasoconstriction, angiotensin 2 exerts strong pro-inflammatory and pro-thrombotic effects, and a concomitant dysregulation of the RAAS may lead to endothelial dysfunction, effects that have been proposed to collectively promote coagulopathy in COVID-19 patients [105]. This evidence concerns the gene AGT and COVID-19.